12.09.2014 • News

Bayer to Add Second Line to Indian TPU Plant

Bayer MaterialScience (BMS) has announced plans to add a 3,500 t/y production train to its Desmopan thermoplastic elastomers (TPU) plant at Cuddalore in India'sTamil Nadu state. The new capacity will lift total output capability at the facility to 6,000 t/y when it goes on stream in the second quarter of 2015.

The Cuddalore plant facility supplies the Indian market and also exports to Europe.

Marius Wirtz, head of the TPU business at BMS, said the planned increase of local capacity is an "important milestone to continuously support our customer's growth with custom-made TPUs in high-quality and with short lead times."

The company is the sole TPU producer in India.

Ajay Durrani, BMS country representative for the Indian subcontinent, said, the company continues to see strong growth opportunities in India across all business units.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.